Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy

被引:372
作者
Arroyave-Ospina, Johanna C. [1 ]
Wu, Zongmei [1 ]
Geng, Yana [1 ]
Moshage, Han [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, NL-9713 GZ Groningen, Netherlands
关键词
oxidative stress; ROS; antioxidant response; non-alcoholic liver disease; lipotoxicity; lipid metabolism; ER stress; mitochondrial dysfunction; antioxidant compounds; ENDOPLASMIC-RETICULUM STRESS; NF-KAPPA-B; IMPROVES HEPATIC STEATOSIS; UNFOLDED PROTEIN RESPONSE; TRANSCRIPTION FACTOR NRF2; DE-NOVO LIPOGENESIS; VITAMIN-E; REACTIVE OXYGEN; ER STRESS; LIPID-METABOLISM;
D O I
10.3390/antiox10020174
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxidative stress (OxS) is considered a major factor in the pathophysiology of inflammatory chronic liver diseases, including non-alcoholic liver disease (NAFLD). Chronic impairment of lipid metabolism is closely related to alterations of the oxidant/antioxidant balance, which affect metabolism-related organelles, leading to cellular lipotoxicity, lipid peroxidation, chronic endoplasmic reticulum (ER) stress, and mitochondrial dysfunction. Increased OxS also triggers hepatocytes stress pathways, leading to inflammation and fibrogenesis, contributing to the progression of non-alcoholic steatohepatitis (NASH). The antioxidant response, regulated by the Nrf2/ARE pathway, is a key component in this process and counteracts oxidative stress-induced damage, contributing to the restoration of normal lipid metabolism. Therefore, modulation of the antioxidant response emerges as an interesting target to prevent NAFLD development and progression. This review highlights the link between disturbed lipid metabolism and oxidative stress in the context of NAFLD. In addition, emerging potential therapies based on antioxidant effects and their likely molecular targets are discussed.
引用
收藏
页码:1 / 25
页数:24
相关论文
共 206 条
[1]   Mouse model of liver ischemia and reperfusion injury: method for studying reactive oxygen and nitrogen metabolites in vivo [J].
Abe, Yuta ;
Hines, Ian N. ;
Zibari, Gazi ;
Pavlick, Kevin ;
Gray, Laura ;
Kitagawa, Yuko ;
Grisham, Matthew B. .
FREE RADICAL BIOLOGY AND MEDICINE, 2009, 46 (01) :1-7
[2]   Role of mitochondria and mitochondria-targeted agents in non-alcoholic fatty liver disease [J].
Ajith, Thekkuttuparambil Ananthanarayanan .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2018, 45 (05) :413-421
[3]   Mitigation of 5-fluorouracil-induced liver damage in rats by vitamin C via targeting redox-sensitive transcription factors [J].
Al-Asmari, A. K. ;
Khan, A. Q. ;
Al-Masri, N. .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2016, 35 (11) :1203-1213
[4]  
Alkhouri Naim, 2009, Expert Rev Gastroenterol Hepatol, V3, P445, DOI 10.1586/egh.09.32
[5]   Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials [J].
Amanullah, Iram ;
Khan, Yusra Habib ;
Anwar, Iqraa ;
Gulzar, Aqsa ;
Mallhi, Tauqeer Hussain ;
Raja, Ahsan Aftab .
POSTGRADUATE MEDICAL JOURNAL, 2019, 95 (1129) :601-611
[6]   Molecular Strategies for Targeting Antioxidants to Mitochondria: Therapeutic Implications [J].
Apostolova, Nadezda ;
Victor, Victor M. .
ANTIOXIDANTS & REDOX SIGNALING, 2015, 22 (08) :686-729
[7]   Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders [J].
Aron-Wisnewsky, Judith ;
Vigliotti, Chloe ;
Witjes, Julia ;
Le, Phuong ;
Holleboom, Adriaan G. ;
Verheij, Joanne ;
Nieuwdorp, Max ;
Clement, Karine .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (05) :279-297
[8]   Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease [J].
Ashraf, N. U. ;
Sheikh, T. A. .
FREE RADICAL RESEARCH, 2015, 49 (12) :1405-1418
[9]   Levels of serum vitamin A, alpha-tocopherol and malondialdehyde in patients with non-alcoholic steatohepatitis: relationship with histopathologic severity [J].
Bahcecioglu, IH ;
Yalniz, M ;
Ilhan, N ;
Ataseven, H ;
Ozercan, IH .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (03) :318-323
[10]   The protective effect of the natural compound hesperetin against fulminant hepatitis in vivo and in vitro [J].
Bai, Xueting ;
Yang, Peixuan ;
Zhou, Qiaoling ;
Cai, Bozhi ;
Buist-Homan, Manon ;
Cheng, He ;
Jiang, Jiyang ;
Shen, Daifei ;
Li, Lijun ;
Luo, Xiajiong ;
Faber, Klaas Nico ;
Moshage, Han ;
Shi, Ganggang .
BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (01) :41-56